STEMart Announces Comprehensive Development Services for the Medical Device Industry

STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety

Filter Testing Services for Pharmaceutical and Medical Device Manufacturers

STEMart Launches Disinfection Efficacy Studies Services for Medical Devices

STEMart Announces Rapid Endotoxin Testing Services for Medical Devices

STEMart recently announced the launch of new Radiation Quarterly Dose Audits (QDAs) Services.

STEMart recently announced the launch of new Ethylene Oxide Sterilant Residual Testing services.

STEMart announces the launch of its new Particulate Matter Testing Services.

STEMart is pleased to announce that it offers Disinfection Validation Services for reusable medical devices.

STEMart has recently introduced a series of Reprocessing Validation services to verify reprocessing instructions for reusable devices.

STEMart has recently introduced the Bioburden and Sterility Testing services for medical devices.

STEMart has recently introduced the Limulus Amebocyte Lysate (LAL) Testing Services under the guidance of industrial standards.

STEMart has recently introduced Bioburden Tissue Testing services for medical applications, including Aerobic Count, Anaerobic Count, Fungi/Mold Count, and Spore Count.